9cannabisbusinessinsights.comMARCH 2026A significant turning point in the field of immunology was the clonal selection theory developed by Talmage in the 1950s and by Jerne and Burnet in the 1960s. It revolutionized our understanding of how the immune system recognizes and responds to antigens. Understanding the history of immunology provides a foundation to grasp the intricate mechanisms of our immune system.At its most basic, the immune system defends the body by distinguishing between 'self' and 'non-self' and consequently mounting a response through its two fundamentally different lines of defense ­ the innate immune system, inherited from invertebrates, and the adaptive immune system, found only in vertebrates. The innate (natural) immune system's response includes physical, chemical, and microbiological barriers, which work rapidly to detect and destroy foreign invaders encountered in daily life. The acquired (adaptive) immune system's response involves specialized T and B cells, which can recognize and mount a rapid response (immunologic memory) after initial contact (immunologic priming) with the foreign invaders. The immune system, through its innate and adaptive responses, works in a perfect symphony to maintain good health, which is essential for the survival of humans.However, when the immune system malfunctions, it can lead to problems both by being underactive - resulting in severe infections and tumors due to immunodeficiency, such as microbial infections in the lungs; or overactive - leading to chronic inflammation and autoimmune diseases, such as autoimmune thyroiditis, Addison disease, and Kawasaki disease. The diseases that arise as a consequence of dysfunction of the immune system not only have a significant impact on the patients and their families but also have a wide-ranging effect on the healthcare system and costs, given the high morbidity and mortality for some of these diseases. The most common therapies for immune dysfunction diseases have usually involved non-specific immune-modulating or immunosuppressive agents such as systemic corticosteroids, which also have associated short- and long-term adverse events because of their non-specificity.There was a need for scientists to target specific parts of an antigen, offering more precision and improving therapeutic outcomes. In 1975, Milstein and Kohler discovered a method to produce monoclonal antibodies through the hybridoma technique, revolutionizing the immune therapeutics field. In the 1980s, monoclonal antibodies were used in laboratories and were essential in identifying and isolating cells and proteins, and by 1986, they were used to prevent organ transplant rejection. The first breakthrough in monoclonal antibody treatment was achieved in 1997 with the regulatory approval of rituximab (a monoclonal antibody targeted against CD20 found on the surface of B cells) for non-Hodgkin's lymphoma. By the 2000s, monoclonal antibodies were being used for various autoimmune conditions like rheumatoid arthritis and Crohn's disease and also to lower cholesterol. The discovery and development of nanobodies in the 1990s has further revolutionized the field of immune therapeutics: these are smaller than monoclonal antibodies and thus expand the possibility of use in therapeutics and can be used in inhalable forms.Thanks to the remarkable complexity, versatility, and accessibility of the immune system and the advances in molecular biological techniques, we have gained an unprecedented understanding of how the human immune system works. This knowledge, coupled with technological advances such as the development of monoclonal antibodies and nanobodies, has presented an exciting opportunity for developing vaccines for millions of people, treatments for patients without adequate therapeutic options, or those inadequately managed with conventional therapies. However, challenges remain as we still do not have vaccines for many diseases such as HIV, Hepatitis C, or malaria, and the danger of reemergence of previously eradicated diseases or bringing the world to a grinding halt, such as with the COVID-19 pandemic, looms large.While we have made significant progress in understanding the human immune system and developing targeted therapies, it is evident that we have only scratched the surface, and much more is to be learned and discovered. The future of immunology offers numerous challenges but also promises discoveries that will advance our knowledge of the immune system and how we can harness it to maintain good health, prevent disease, and treat diseases when they occur. The rapid development and global cooperation seen in the creation of COVID-19 vaccines is undoubtedly a beacon of hope for future endeavors in the field of immunology.Also, in developing these treatments, we must consider the differences and disparities in the demographic, socioeconomic, and environmental factors, as susceptibility to immunological diseases may be impacted by these factors. It is also essential to address questions regarding access to these medications. This would ensure that advances in the field of immunology benefit patients with high unmet needs, reduce the impact on health systems, and lead to an equitable and healthier future. The immune system, through its innate and adaptive responses, works in a perfect symphony to maintain good health, which is essential for the survival of humans.
< Page 8 | Page 10 >